Alkermes : Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2021 and Provides Financial Expectations for 2022 - Form 8-K

GAAP Net Loss






-

... | February 16, 2022

Related Keywords

United States ,Massachusetts ,Athlone ,Westmeath ,Ireland ,Ohio ,Waltham ,Dublin ,Kenilworth ,American ,Iain Brown ,Catot Laurencin ,Janssen Pharmaceutica ,American Society Of Clinical Oncology ,Psych Congress ,Rodin Therapeutics Inc ,Neuroscience Education Institute ,Nasdaq ,Merck Co Inc ,Johnson Company ,Alkermes Inc ,International Society For Affective Disorders ,Alkermes ,Society For Immunotherapy Of Cancer ,Development Revenues ,Merck Sharp Dohme Corp ,Exchange Commission ,Biogen Ma Inc ,Alkermes Pharma Ireland ,Reports Financial Results ,Fourth Quarter ,Year Ended ,Provides Financial Expectations ,Proprietary Products ,Continued Operating Efficiency ,Richard Pops ,Chief Executive Officer ,Goods Manufactured ,Rodin Therapeutics ,Chief Financial Officer ,Goods Sold ,Intangible Assets ,International Society ,Affective Disorders ,American Society ,Clinical Oncology ,Cancers Symposium ,Sarissa Capital Management ,Private Securities Litigation Reform Act ,Annual Report ,Alkermes Pharma Ireland Limited ,Merck Sharp ,Dohme Corp ,Additional Information ,General Meeting ,Information Regarding Participants ,Current Reports ,Initial Statements ,Beneficial Ownership ,Financial Information ,Consolidated Statements ,Before Income Taxes ,Per Share ,Average Number ,Ordinary Shares Outstanding ,Earnings Per Share ,Shareholder Equity ,Calendar Year ,Net Loss ,Alkermes Plc Stock Exchange ,News ,Information ,Press Release ,Aap ,Et Alks Ie00b56gvs15 ,